⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABOS News
Acumen Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
globenewswire.com
ABOS
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
globenewswire.com
ABOS
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
globenewswire.com
ABOS
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
ABOS